Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac IPO & Placement Research, China biotech

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Capital Markets

China Unicom Hong Kong / Equity Capital Markets

<p><a href="https://www.smartkarma.com/entities/1016" target="_blank" data-smartkarma-citation="entities:1016:1">China Unicom Hong Kong Ltd</a> , one of the three major telecom service providers in China, sees its shareholder <a href="https://www.smartkarma.com/entities/21299" target="_blank" data-smartkarma-citation="entities:21299:1">Telefonica SA</a> placing 361m shares worth US$360m. </p><p>The deal scores below borderline for participation in our ECM framework, mainly because of its poor share performance, placement track record, recent stock derating, and higher leverage than peers. We also take a quick look at its fundamentals.</p><h2>Deal Overview</h2><ul>
<li>Company Name: China Unicom Hong Kong Ltd</li>
<li>Ticker: 762 HK Equity</li>
<li>Secondary offering </li>
<li>…</li>
</ul>

China Unicom Hong Kong Ltd , one of the three major telecom service providers in China, sees its shareholder Telefonica SA placing 361m shares worth US$360m. The deal scores below borderline for participation in our ECM framework, mainly because of its poor share performance, placement track record, recent stock derating, and higher leverage than peers. We also take a quick look at its fundamentals.Deal Overview
Company Name: China Unicom Hong Kong Ltd
Ticker: 762 HK Equity
Secondary offering 
…


China Unicom Placement: Worst Performing Chinese Telco, Albeit Turn-Around Potential